<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03868631</url>
  </required_header>
  <id_info>
    <org_study_id>01435225</org_study_id>
    <nct_id>NCT03868631</nct_id>
  </id_info>
  <brief_title>Muscle Growth Following a Resistance Training Program in Men and Women Consuming Protein Supplements</brief_title>
  <official_title>Muscle Growth and Development Following a 12-week Resistance Training Program in Men and Women Consuming Soy and Whey Protein Supplements</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Point Loma Nazarene University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Point Loma Nazarene University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Soy and whey protein have different concentrations of leucine, an amino acid known to be a
      particularly potent simulator of muscle protein synthesis. The purpose of this study is to
      determine whether matching soy and whey protein supplements for leucine content instead of by
      total protein content would contribute to differences in strength increases and muscle growth
      in response to 12 wk of resistance training.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 15, 2016</start_date>
  <completion_date type="Actual">April 30, 2017</completion_date>
  <primary_completion_date type="Actual">April 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lean Body Mass Change</measure>
    <time_frame>Post-12 week intervention</time_frame>
    <description>assessed using dual energy x-ray absorptiometry (DEXA) scan for changes in lean body mass (kg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle Tissue Thickness Change</measure>
    <time_frame>Post-12 week intervention</time_frame>
    <description>assessed using changes in muscle thickness assessed by ultrasound (cm)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Leg Girth Changes</measure>
    <time_frame>Post-12 week intervention</time_frame>
    <description>assessed using circumference measurements (cm)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Peak Torque When Doing Leg Extensions</measure>
    <time_frame>Post-12 week intervention</time_frame>
    <description>Assessed using an isokinetic dynamometer set at 60 degrees of motion per second (d/s)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Skeletal Muscle Growth</condition>
  <arm_group>
    <arm_group_label>Soy protein group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Whey protein group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whey protein supplement</intervention_name>
    <description>19 g whey protein isolate (contains 2 g leucine) was consumed daily by one intervention group.</description>
    <arm_group_label>Whey protein group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Soy protein supplement</intervention_name>
    <description>26 g soy protein isolate (contains 2 g leucine) was consumed daily by the other intervention group.</description>
    <arm_group_label>Soy protein group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  non-smoking

          -  body mass index (BMI) 18.5-24.9

          -  recreationally active

        Exclusion Criteria:

          -  participated in structured weight training during the previous 12 month

          -  vegetarian or vegan

          -  presence of chronic disease

          -  pregnant, postpartum up to six months, lactating, or intention to become pregnant

          -  allergy to whey or soy

          -  changes in body weight more than 10 pounds in the past three months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heidi Lynch, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Point Loma Nazarene University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arizona State University</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 25, 2019</study_first_submitted>
  <study_first_submitted_qc>March 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2019</study_first_posted>
  <results_first_submitted>February 3, 2020</results_first_submitted>
  <results_first_submitted_qc>February 25, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 27, 2020</results_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Point Loma Nazarene University</investigator_affiliation>
    <investigator_full_name>Heidi Lynch</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 1, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/31/NCT03868631/Prot_004.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 1, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/31/NCT03868631/SAP_005.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 27, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/31/NCT03868631/ICF_006.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>282 people responded to the screening survey online from August 2016 through January 2017. Data collection was completed by May 2017. 61 participants were randomized for study participation. Recruitment emails were sent to students at Arizona State University and others were contacted via word of mouth.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Soy Protein Group</title>
          <description>Soy protein supplement: 26 g soy protein isolate (contains 2 g leucine) was consumed daily by the other intervention group.</description>
        </group>
        <group group_id="P2">
          <title>Whey Protein Group</title>
          <description>Whey protein supplement: 19 g whey protein isolate (contains 2 g leucine) was consumed daily by one intervention group.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Baseline to Week 6</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Week 6 to Week 12 (Study Completion)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Soy Protein Group</title>
          <description>Soy protein supplement: 26 g soy protein isolate (contains 2 g leucine) was consumed daily by the other intervention group.</description>
        </group>
        <group group_id="B2">
          <title>Whey Protein Group</title>
          <description>Whey protein supplement: 19 g whey protein isolate (contains 2 g leucine) was consumed daily by one intervention group.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="31"/>
            <count group_id="B3" value="61"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21.83" spread="4.27"/>
                    <measurement group_id="B2" value="22.22" spread="3.38"/>
                    <measurement group_id="B3" value="22.03" spread="3.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Ethnicity</title>
              <category_list>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Non-white</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="166.93" spread="10.03"/>
                    <measurement group_id="B2" value="168.20" spread="7.04"/>
                    <measurement group_id="B3" value="167.57" spread="8.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.5" spread="13.3"/>
                    <measurement group_id="B2" value="66.9" spread="10.1"/>
                    <measurement group_id="B3" value="66.26" spread="11.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Lean body mass</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.084" spread="10.2896"/>
                    <measurement group_id="B2" value="44.486" spread="8.7167"/>
                    <measurement group_id="B3" value="44.301" spread="9.3816"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Appendicular lean body mass</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19.81796" spread="5.353628"/>
                    <measurement group_id="B2" value="20.32806" spread="5.096195"/>
                    <measurement group_id="B3" value="20.09263" spread="5.171179"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fat mass</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19.71463" spread="6.818858"/>
                    <measurement group_id="B2" value="20.21259" spread="6.261987"/>
                    <measurement group_id="B3" value="19.97825" spread="6.468543"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body fat percent</title>
          <units>percent body fat</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.92083" spread="8.227645"/>
                    <measurement group_id="B2" value="31.38214" spread="8.163188"/>
                    <measurement group_id="B3" value="31.16923" spread="8.115504"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Vastus lateralis thickness</title>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.167615" spread="0.3136369"/>
                    <measurement group_id="B2" value="2.330765" spread="0.5032904"/>
                    <measurement group_id="B3" value="2.253989" spread="0.4286374"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Vastus intermedius thickness</title>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.563921" spread="0.3433793"/>
                    <measurement group_id="B2" value="1.572045" spread="0.4095149"/>
                    <measurement group_id="B3" value="1.568222" spread="0.3761121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Peak torque doing leg extensions (60 d/s)</title>
          <units>Newton-meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="132.0228" spread="44.87827"/>
                    <measurement group_id="B2" value="124.3479" spread="39.91502"/>
                    <measurement group_id="B3" value="127.8901" spread="42.03202"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Peak torque doing leg flexions (60 d/s)</title>
          <units>Newton-meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.2884" spread="15.04077"/>
                    <measurement group_id="B2" value="60.4792" spread="15.85495"/>
                    <measurement group_id="B3" value="62.2373" spread="15.45260"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Lean Body Mass Change</title>
        <description>assessed using dual energy x-ray absorptiometry (DEXA) scan for changes in lean body mass (kg)</description>
        <time_frame>Post-12 week intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Soy Protein Group</title>
            <description>Soy protein supplement: 26 g soy protein isolate (contains 2 g leucine) was consumed daily by the other intervention group.</description>
          </group>
          <group group_id="O2">
            <title>Whey Protein Group</title>
            <description>Whey protein supplement: 19 g whey protein isolate (contains 2 g leucine) was consumed daily by one intervention group.</description>
          </group>
        </group_list>
        <measure>
          <title>Lean Body Mass Change</title>
          <description>assessed using dual energy x-ray absorptiometry (DEXA) scan for changes in lean body mass (kg)</description>
          <units>kilogram</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.4"/>
                    <measurement group_id="O2" value="1.3" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Between-group differences at baseline were compared using independent t-tests. Multilevel models for change (MLM) were used to determine differences between groups over time for study outcomes. Age, sex, and number of sessions missed were included as covariates. Time and time by group interactions were examined. Analyses were conducted using IBM SPSS Statistics version 23. Significance was set at p&lt;0.05.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>multilevel models for change</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Muscle Tissue Thickness Change</title>
        <description>assessed using changes in muscle thickness assessed by ultrasound (cm)</description>
        <time_frame>Post-12 week intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Soy Protein Group</title>
            <description>Soy protein supplement: 26 g soy protein isolate (contains 2 g leucine) was consumed daily by the other intervention group.</description>
          </group>
          <group group_id="O2">
            <title>Whey Protein Group</title>
            <description>Whey protein supplement: 19 g whey protein isolate (contains 2 g leucine) was consumed daily by one intervention group.</description>
          </group>
        </group_list>
        <measure>
          <title>Muscle Tissue Thickness Change</title>
          <description>assessed using changes in muscle thickness assessed by ultrasound (cm)</description>
          <units>centimeter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.16"/>
                    <measurement group_id="O2" value="0.05" spread="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Leg Girth Changes</title>
        <description>assessed using circumference measurements (cm)</description>
        <time_frame>Post-12 week intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Soy Protein Group</title>
            <description>Soy protein supplement: 26 g soy protein isolate (contains 2 g leucine) was consumed daily by the other intervention group.</description>
          </group>
          <group group_id="O2">
            <title>Whey Protein Group</title>
            <description>Whey protein supplement: 19 g whey protein isolate (contains 2 g leucine) was consumed daily by one intervention group.</description>
          </group>
        </group_list>
        <measure>
          <title>Leg Girth Changes</title>
          <description>assessed using circumference measurements (cm)</description>
          <units>centimeter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1865" spread="0.05254"/>
                    <measurement group_id="O2" value="-0.0084" spread="0.06227"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Peak Torque When Doing Leg Extensions</title>
        <description>Assessed using an isokinetic dynamometer set at 60 degrees of motion per second (d/s)</description>
        <time_frame>Post-12 week intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Soy Protein Group</title>
            <description>Soy protein supplement: 26 g soy protein isolate (contains 2 g leucine) was consumed daily by the other intervention group.</description>
          </group>
          <group group_id="O2">
            <title>Whey Protein Group</title>
            <description>Whey protein supplement: 19 g whey protein isolate (contains 2 g leucine) was consumed daily by one intervention group.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Peak Torque When Doing Leg Extensions</title>
          <description>Assessed using an isokinetic dynamometer set at 60 degrees of motion per second (d/s)</description>
          <units>Newton-meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.1" spread="13.5"/>
                    <measurement group_id="O2" value="18.0" spread="16.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Soy Protein Group</title>
          <description>Soy protein supplement: 26 g soy protein isolate (contains 2 g leucine) was consumed daily by the other intervention group.</description>
        </group>
        <group group_id="E2">
          <title>Whey Protein Group</title>
          <description>Whey protein supplement: 19 g whey protein isolate (contains 2 g leucine) was consumed daily by one intervention group.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>hip pain</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title vocab="Abdominal pain">Abdominal pain</sub_title>
                <description>Baseline-week 6</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="31"/>
              </event>
              <event>
                <sub_title vocab="Vomited">Vomited</sub_title>
                <description>Baseline-week 6</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Hip pain</sub_title>
                <description>Week 6-week 12</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="31"/>
              </event>
              <event>
                <sub_title vocab="Knee pain">Knee pain</sub_title>
                <description>Baseline-week 6</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="31"/>
              </event>
              <event>
                <sub_title vocab="knee pain">Knee pain</sub_title>
                <description>Week 6-week 12</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>No non-protein control (ex: placebo, maltodextrin)
No objective measurement of physical activity outside of the exercise intervention
No objective verification if the participants consumed protein powder on non-training days</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Heidi Lynch</name_or_title>
      <organization>Point Loma Nazarene University</organization>
      <phone>619-806-3306</phone>
      <email>hlynch@pointloma.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

